Join our community of smart investors

C&C adjusts to new deal with AB InBev

The new deal with AB InBev is causing some short-term pain in order to reap the long-term benefits of distribution by the world's largest brewer
October 30, 2017

These results from C&C Group (CCR) reflect transition pains as part of the "revised commercial terms" with AB InBev, announced just before May's full-year results. Under the terms of the new arrangements, C&C’s distribution rights for AB InBev’s products in the UK have reverted to the latter entity, resulting in an overall fall in volumes for C&C. However, chief executive Stephen Glancey said that any short-term pain was worth the long-term gain, as scale benefits accrue from having the world’s largest brewer distribute its products. For now, however, the 7 per cent decline in total volumes weighed on interim sales and profits.

IC TIP: Buy at 2.96€

Distribution aside, C&C is benefiting from increasing discernment on the part of UK drinkers. Sales of craft and super-premium ciders were up by 27 per cent over the six months to €7.8m (£6.88m). This switch to premium brands, along with cost savings from the re-jigged AB InBev arrangements, helped the operating margin improve by 40 basis points to 17.9 per cent.

Analysts at Davy expect pre-tax profits of €81m in the year to February 2018, giving EPS of 22.4¢, with estimates broadly flat for FY2019.

C&C GROUP (CCR)   
ORD PRICE:296¢MARKET VALUE:€915m
TOUCH:296-297¢12-MONTH HIGH:419¢LOW: 285¢
DIVIDEND YIELD:4.9%PE RATIO:NA
NET ASSET VALUE:161¢*NET DEBT:31%
Half-year to 31 AugTurnover (€m)Pre-tax profit (€m)Earnings per share (¢)Dividend per share (¢)
201645050.313.84.96
201740846.012.75.21
% change-9-9-8+5
Ex-div:02 Nov   
Payment:15 Dec   
*Includes intangible assets of €527m, or 170¢ per share  £1=€1.13